PBMs’ incentives to engage in exclusionary rebates warrant more scrutiny, FTC says

By Khushita Vasant (July 16, 2024) -- Concentration among pharmacy benefit managers is increasing, with vertical integration having raised various competitive concerns in the drug supply chain in the US as well as financial conflicts of interest which should be investigated further, the Federal Trade Commission said....

Related Sections